1
0
0
(1 - 30 von 45
)
Andreas Calatzis on LinkedIn: Energie: Atomkraft nur im Notfall ...www.linkedin.com › posts
www.linkedin.com
Andreas Calatzis. 5d. Report this post. Die wirklich gute Nachricht ist, dass CO2 Ausstoss und Gasmangel offenbar nicht so dramatisch sind.
Andreas Calatzis | Professional Profile - LinkedInwww.linkedin.com › andreas-calatz...
www.linkedin.com
View Andreas Calatzis' profile on LinkedIn, the world's largest professional community. Andreas has 3 jobs listed on their profile. See the complete profile on ...
Andreas Calatzis | LinkedIn
www.linkedin.com
View Andreas Calatzis's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Andreas Calatzis discover ...
Combination therapy with coagulation factors and ...
patents.google.com
Application number: PCT/EP ; Other languages: English (en) · French (fr); Inventor: Andreas Calatzis: Katharina LECHNER; Original Assignee ... › patent
Device for measuring the coagulation properties of test liquids
www.google.com
Application filed by Calatzis Andreas, Calatzis Alexander, Fritzsche Pablo Priority to DE U Publication of DE U1. › patents
Andreas Calatzis, Munich, Germany
www.northdata.com
Company publications and network for Andreas Calatzis: eonis GmbH, enicor GmbH, Dynabyte - Informationssysteme GmbH, previously: Verum Diagnostica ...
Clinical Laboratory
www.clin-lab-publications.com
... -Rich Plasma and Whole Blood by Robert Zimmermann, Julia Krueger, Miloš R. Filipović, Ivana Ivanović-Burmazović, Andreas Calatzis, Dominik R. Weiss,
A detailed examination of platelet function inhibition by nitric...
pubmed.ncbi.nlm.nih.gov
Whole blood versus PLT rich plasma, citrate versus hirudin, and high versus low shear influenced the effects of NO. This shows that a careful selection of...
An evaluation of cyclooxygenase-1 inhibition before coronary artery...
pubmed.ncbi.nlm.nih.gov
Our results suggest that arachidonic …-induced aggregation in whole blood may be a better predictor of platelet-related coagulopathy and platelet...
ClotPro System - viskoelastometri-analysator - Nordic Biolabs
www.nordicbiolabs.se
Systemet är framtaget av Andreas Calatzis, en välkänd profil som ligger bakom ett flertal andra lösningar för tromboelastometri och är en pionjär inom ... › visk...
Platelet Transmission Electron Microscopy and Flow Cytometry
docplayer.net
Dr. Andreas Calatzis PD Dr. Michael Spannagl Department for Haemostasis and Transfusion Medicine Munich University Clinic Ludwig-Maximilians University …
Download Figures (PPT) - Thrombosis Research
www.thrombosisresearch.com
Martin Ponschab, MD, Martijn van Griensven, PhD, Stefan Heitmeier, PhD, Volker Laux, PhD, Christoph J. Schlimp, MD, Andreas Calatzis, MD, Soheyl Bahrami, ... › article › ppt
Ex Parte Calatzis et al, (D) | Casetext
casetext.com
... NY FIRST NAMED INVENTOR Andreas Calatzis UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER ... › admin-law
GLYCARDIAL DIAGNOSTICS SL - Informe de empresa
www.datoscif.es
GLYCARDIAL DIAGNOSTICS SL Cubedo Rafols Judit Badimon Maestro Lina CAIXA CAPITAL RISC SGEIC SA HEALTHEQUITY SCR SA Andreas Calatzis RIVA Y GARCIA PROYECTOS ... › empresa
GLYCARDIAL DIAGNOSTICS SL, BARCELONA - Infocif
infocif.economia3.com
¿Perteneces a esta empresa y quieres proponer un cambio? Sector. Cuidado de la salud. Nº de empleados. -. Cargos directivos -. ANDREAS CALATZIS Ver más. › gl...
Effects and interferences of emicizumab, a Europe PMC
europepmc.org
von JI Adamkewicz · · Zitiert von: 7 — We thank Andreas Calatzis, MD for his assistance with an early draft of this manuscript. Writing assistance for this manuscript was provided by Maria Alfaradhi, ... › articles › bin
Hamostaseologie - OA.mg
oa.mg
K.-W. von Pape, M. Dzijan-Horn, J. Bohner, Michael Spannagl, H. Weisser, Andreas Calatzis. Platelet. Medicine. Gynecology · DOI: ha › journal › hamostase...
Haemonetics acquires Enicor - TMG Pulse
tmgpulse.com
Enicor CEO Dr. Andreas Calatzis is set to join Haemonetics as VP & GM of Enicor and work closely with the company's R&D and clinical functions departments. › haemonetic...
LTEN Industry & Member - Haemonetics Acquires Enicor
lten-industrybrief.caboodleai.net
Enicor CEO Dr. Andreas Calatzis is set to join Haemonetics as VP & GM of Enicor and work closely with the company's R&D and clinical ...
Improved clot formation by combined administration PubMed
pubmed.ncbi.nlm.nih.gov
von KA Tanaka · · Zitiert von: 76 — Authors. Kenichi A Tanaka , Taro Taketomi, Fania Szlam, Andreas Calatzis, Jerrold H Levy. Affiliation. 1 Department of Anesthesiology, Division of ... › ...
Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic...
www.distilnfo.com
... Dr. Andreas Calatzis, CEO and founder of enicor GmbH. “With its leadership position in whole blood coagulation testing and its global reach, ...
Prothrombinase-induced clotting time assay for determination ...
pubmed.ncbi.nlm.nih.gov
von A Calatzis · · Zitiert von: 56 — Sep;130(3): doi: Q0G21Y26UR0UHQ1A. Authors. Andreas Calatzis , ... von KA Tanaka · · Zitiert von: 76 — Authors. Kenichi A Tanaka , Taro Taketomi, Fania Szlam, Andreas Calatzis, Jerrold H Levy. Affiliation. 1 Department of Anesthesiology, Division of ... › ...
MolMed - Centre of Excellence in Molecular Medicine
a.umed.pl
Dr Andreas Calatzis. graduated from the Medical School of the Technische Universitaet Munich in In the period of he was research assistant ... › afisz_23_eng
Spontaneous platelet aggregation | Related Topics - Typeset.io
typeset.io
Orsolya Tóth 1, Andreas Calatzis, Sandra M Penz, Hajna Losonczy, Wolfgang Siess - Show less +1 more • Institutions (1). › topics
WHAT | QCDC
www.qcdc.eu
Andreas Calatzis who was the founder of Multiplate Diagnostics in Munich Germany. From through Mr. Hill worked as a consultant for Multiplate, ... › ...
Alle Infos zum Namen "Andreas Calatzis"
sortiert nach Relevanz / Datum